Deal Watch: Pfizer, Allergan Continue Deal-Making Ahead Of Merger
Executive Summary
Novo Nordisk aligns with Xoma to develop monoclonal antibodies that could up-regulate the insulin receptor, and also signs an R&D pact with Ablynx. Takeda and Teva agree to joint venture in Japan built around the Japanese pharma's mature products.